<?xml version="1.0"?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2014//EN" "http://www.ncbi.nlm.nih.gov/corehtml/query/DTD/pubmed_140101.dtd">
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">29748907</PMID>
        <DateCompleted>
            <Year>2019</Year>
            <Month>03</Month>
            <Day>07</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2019</Year>
            <Month>03</Month>
            <Day>07</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1437-7799</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>22</Volume>
                    <Issue>6</Issue>
                    <PubDate>
                        <Year>2018</Year>
                        <Month>Dec</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Clinical and experimental nephrology</Title>
                <ISOAbbreviation>Clin Exp Nephrol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Effect of combined vitamin D receptor activator and lanthanum carbonate on serum fibroblast growth factor 23 level in predialysis patients (CVD-LAF study): design and method.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1309-1314</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s10157-018-1584-0</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Whether vitamin D receptor activator (VDRA) use is beneficial in chronic kidney disease (CKD) is unclear, because it is possible that VDRA increases serum fibroblast growth factor 23 (FGF23) levels. We will conduct a randomized controlled trial in predialysis patients to determine the effect of VDRA alone or in combination with lanthanum carbonate (LC) on serum FGF23 levels.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">This is a single-center, open-label, randomized controlled trial. Enrollment will commence February 1, 2018, using the following inclusion criteria: (1) ageââ¥â20 years, (2) CKD with an estimated glomerular filtration rate of 10-45Â mL/min/1.73Â m<sup>2</sup>, (3) serum adjusted calcium levelâ&lt;â9.5Â mg/dL, (4) serum phosphate level 4.0-6.0Â mg/dL, and (5) serum intact parathyroid hormone (PTH) levelââ¥â60Â pg/mL. Study patients will be randomized 1:1 to receive alfacalcidol alone or in combination with LC. The initial dose of alfacalcidol will be 0.25-0.5Â Âµg once a day according to serum adjusted calcium level. The initial dose of LC will be 250Â mg once a day. We will measure serum intact and C-terminal FGF23 at 0, 4, 8, 12, 24, and 52 weeks. The primary outcome will be serum FGF23 level at 24 weeks compared with baseline.</AbstractText>
                <AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">This study aims to determine whether low-dose oral VDRA increases serum FGF23 level and whether the combination of VDRA and LC inhibits this increase. The results will be useful in the management of CKD-mineral and bone disorder in predialysis patients.</AbstractText>
                <AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">UMIN000030503. Registered 20 January 2018.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Ito</LastName>
                    <ForeName>Eri</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Nephrology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Inaguma</LastName>
                    <ForeName>Daijo</ForeName>
                    <Initials>D</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-3977-5933</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Nephrology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan. daijo@fujita-hu.ac.jp.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Koide</LastName>
                    <ForeName>Shigehisa</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Nephrology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Takahashi</LastName>
                    <ForeName>Kazuo</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Nephrology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hayashi</LastName>
                    <ForeName>Hiroki</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Nephrology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hasegawa</LastName>
                    <ForeName>Midori</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Nephrology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yuzawa</LastName>
                    <ForeName>Yukio</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Nephrology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2018</Year>
                <Month>05</Month>
                <Day>10</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Japan</Country>
            <MedlineTA>Clin Exp Nephrol</MedlineTA>
            <NlmUniqueID>9709923</NlmUniqueID>
            <ISSNLinking>1342-1751</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D006887">Hydroxycholecalciferols</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D018167">Receptors, Calcitriol</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>490D9F069T</RegistryNumber>
                <NameOfSubstance UI="C119467">lanthanum carbonate</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>62031-54-3</RegistryNumber>
                <NameOfSubstance UI="D005346">Fibroblast Growth Factors</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>6I3K30563S</RegistryNumber>
                <NameOfSubstance UI="D007811">Lanthanum</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>7Q7P4S7RRE</RegistryNumber>
                <NameOfSubstance UI="C416507">fibroblast growth factor 23</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>URQ2517572</RegistryNumber>
                <NameOfSubstance UI="C008088">alfacalcidol</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D005346" MajorTopicYN="N">Fibroblast Growth Factors</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006887" MajorTopicYN="N">Hydroxycholecalciferols</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007811" MajorTopicYN="N">Lanthanum</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018167" MajorTopicYN="N">Receptors, Calcitriol</DescriptorName>
                <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006435" MajorTopicYN="Y">Renal Dialysis</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D051436" MajorTopicYN="N">Renal Insufficiency, Chronic</DescriptorName>
                <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012107" MajorTopicYN="Y">Research Design</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Alfacalcidol</Keyword>
            <Keyword MajorTopicYN="N">FGF23</Keyword>
            <Keyword MajorTopicYN="N">Lanthanum carbonate</Keyword>
            <Keyword MajorTopicYN="N">Predialysis</Keyword>
            <Keyword MajorTopicYN="N">Vitamin D</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2018</Year>
                <Month>01</Month>
                <Day>29</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2018</Year>
                <Month>04</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2018</Year>
                <Month>5</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>3</Month>
                <Day>8</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2018</Year>
                <Month>5</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">29748907</ArticleId>
            <ArticleId IdType="doi">10.1007/s10157-018-1584-0</ArticleId>
            <ArticleId IdType="pii">10.1007/s10157-018-1584-0</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Circulation. 2009 May 19;119(19):2545-52</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19414634</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Kidney Dis. 2011 Jul;58(1):127-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21496980</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Intern Med. 2013 Feb 5;158(3):200-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23295957</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2010 Nov 6;376(9752):1543-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21055801</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cardiorenal Med. 2017 Dec;8(1):71-81</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29344028</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hypertension. 2008 Aug;52(2):249-55</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18606901</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Med Sci. 2012 Feb 29;8(1):4-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22457665</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2007 Oct 23;104(43):16810-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17942703</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Exp Nephrol. 2010 Feb;14(1):43-50</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19882205</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Invest. 2002 Jul;110(2):229-38</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12122115</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Steroid Biochem Mol Biol. 2007 Mar;103(3-5):381-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17293108</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nephrol Dial Transplant. 2011 Aug;26(8):2567-71</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21436379</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Kidney Int. 2016 Nov;90(5):985-996</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27457912</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Invest. 2011 Nov;121(11):4393-408</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21985788</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2012 Feb 15;307(7):674-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22337679</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Kidney Int. 2008 Jul;74(2):170-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18385669</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Cell Endocrinol. 2016 Sep 5;432:56-65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27178987</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nephrol Dial Transplant. 2012 Jun;27(6):2263-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22140123</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Bone Miner Res. 2004 Mar;19(3):429-35</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15040831</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Nephrol. 2013;37(3):239-48</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23467111</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin J Am Soc Nephrol. 2010 Sep;5(9):1710-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20507957</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Intern Med. 2008 Feb 25;168(4):397-403</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18299495</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Bone Marrow Transplant. 2013 Mar;48(3):452-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23208313</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Endocrinol Metab. 2013 Feb;98(2):550-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23284004</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>In Vivo. 2017 01-02;31(1):145-150</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28064234</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Am Soc Nephrol. 2008 Aug;19(8):1613-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18463168</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Kidney Int. 2017 Mar;91(3):711-719</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28017325</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nephrol Dial Transplant. 2004 Jan;19(1):179-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14671054</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nutr Metab Cardiovasc Dis. 2016 Jul;26(7):581-589</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27113290</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Am Soc Nephrol. 2014 Jan;25(1):175-86</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24052631</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>